PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Pfizer
One to Watch: Q&A with Paul Dyer
Paul Dyer, eMedia Director, WeissComm Group (WCG), is already on his way to the top not only on PR News’ 15 to watch list, but also as an emerging leader in the online healthcare landscape.
At 26, Paul Dyer has a long list of accolades that most young professionals his age only dream about. As eMedia [...]
Posted in Marketing, People Also tagged Advertising and Marketing, GlaxoSmithKline, Health care, Marketing, Mass media, Virgin Megastore, Walgreens Leave a comment
Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger
Image via Wikipedia
After Merck & Co. officially announced its $41.1 billion merger with Schering-Plough yesterday, CEO Richard Clark made it clear his company is still looking to expand through further acquisitions and mergers.
According to the Wall Street Journal’s Health Blog:
Clark told us today that the newly combined company is “actively looking” for biotechs to [...]
Posted in Strategy Also tagged business, Fred Hassan, Merck, Merck & Co, Richard Clark, Schering Plough, Wall Street Journal 2 Comments
Pfizer Quietly Updates Company Logo
A few weeks back, about the time Pfizer started swapping out Wyeth signs for Pfizer branding, I was tipped off that the age-old Pfizer logo had been modified from the horizontal blue oval to an offset design.
Additionally, the company did tiny modifications on each letter, dropping the serif from the “P,” making the “F” less [...]
Posted in Strategy Also tagged Advertising, business, Design, Logo, Pepsi, Typeface, Wyeth 7 Comments
AstraZeneca, BMS Announce Layoffs and Buyouts
AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force.
“AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they are [...]
Posted in Strategy Also tagged AstraZeneca, Bristol Myers Squibb, Buyouts, Indiana, layoffs, New York City, Strategy, Wyeth 1 Comment
Merck, Lilly, Pfizer: One for All and All for One